{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Hormonal+contraception",
    "query": {
      "intervention": "Hormonal contraception"
    },
    "page_size": 10
  },
  "pagination": {
    "page": 1,
    "page_size": 10,
    "total_count": 78,
    "total_pages": 8,
    "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Hormonal+contraception&page=2&page_size=10",
    "previous_page_url": null
  },
  "source": "remote",
  "last_synced_at": "2026-09-06T16:34:38.553Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT00677742",
      "title": "The Impact of Pack Supply on Birth Control Pill Continuation",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Oral Contraception"
      ],
      "interventions": [
        {
          "name": "enhanced initial supply of oral contraception",
          "type": "OTHER"
        },
        {
          "name": "conventional initial supply of oral contraception",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER"
      ],
      "sponsor": "Columbia University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": "35 Years",
        "sex": "FEMALE",
        "summary": "Up to 35 Years · Female only"
      },
      "enrollment_count": 700,
      "start_date": "2007-06",
      "completion_date": "2012-11",
      "has_results": false,
      "last_update_posted_date": "2012-12-12",
      "last_synced_at": "2026-09-06T16:34:38.553Z",
      "location_count": 1,
      "location_summary": "New York, New York",
      "locations": [
        {
          "city": "New York",
          "state": "New York"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00677742"
    },
    {
      "nct_id": "NCT02532361",
      "title": "Proportion of Hysterectomy After Female Sterilization",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Hysterectomy"
      ],
      "interventions": [
        {
          "name": "Hysteroscopic device placement including Essure (ESS305, BAY1454032)",
          "type": "DEVICE"
        },
        {
          "name": "Tubal ligation",
          "type": "PROCEDURE"
        }
      ],
      "intervention_types": [
        "DEVICE",
        "PROCEDURE"
      ],
      "sponsor": "Bayer",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "49 Years",
        "sex": "FEMALE",
        "summary": "18 Years to 49 Years · Female only"
      },
      "enrollment_count": 10578,
      "start_date": "2015-08",
      "completion_date": "2015-12",
      "has_results": false,
      "last_update_posted_date": "2016-12-23",
      "last_synced_at": "2026-09-06T16:34:38.553Z",
      "location_count": 1,
      "location_summary": "New Jersey, New Jersey",
      "locations": [
        {
          "city": "New Jersey",
          "state": "New Jersey"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02532361"
    },
    {
      "nct_id": "NCT00584038",
      "title": "Improving Adolescent Adherence to Hormonal Contraception",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Contraception"
      ],
      "interventions": [
        {
          "name": "educational instruction and phone follow-up",
          "type": "BEHAVIORAL"
        },
        {
          "name": "educational instruction in clinic",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "The University of Texas Medical Branch, Galveston",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "16 Years",
        "maximum_age": "24 Years",
        "sex": "FEMALE",
        "summary": "16 Years to 24 Years · Female only"
      },
      "enrollment_count": 1155,
      "start_date": "2006-01",
      "completion_date": "2012-03",
      "has_results": false,
      "last_update_posted_date": "2013-05-24",
      "last_synced_at": "2026-09-06T16:34:38.553Z",
      "location_count": 1,
      "location_summary": "Galveston, Texas",
      "locations": [
        {
          "city": "Galveston",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00584038"
    },
    {
      "nct_id": "NCT02357368",
      "title": "Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE4"
      ],
      "conditions": [
        "HIV",
        "Contraception"
      ],
      "interventions": [
        {
          "name": "Depot medroxyprogesterone acetate (DMPA)",
          "type": "DRUG"
        },
        {
          "name": "Etonogestrel implant (Eng-Implant)",
          "type": "DEVICE"
        },
        {
          "name": "Levonorgestrel intrauterine device (Lng-IUD)",
          "type": "DEVICE"
        },
        {
          "name": "ParaGard® T 380A Intrauterine Copper Contraceptive",
          "type": "DEVICE"
        }
      ],
      "intervention_types": [
        "DRUG",
        "DEVICE"
      ],
      "sponsor": "Lisa Haddad",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "45 Years",
        "sex": "FEMALE",
        "summary": "18 Years to 45 Years · Female only"
      },
      "enrollment_count": 59,
      "start_date": "2015-02",
      "completion_date": "2019-10-23",
      "has_results": true,
      "last_update_posted_date": "2020-11-18",
      "last_synced_at": "2026-09-06T16:34:38.553Z",
      "location_count": 4,
      "location_summary": "Atlanta, Georgia",
      "locations": [
        {
          "city": "Atlanta",
          "state": "Georgia"
        },
        {
          "city": "Atlanta",
          "state": "Georgia"
        },
        {
          "city": "Atlanta",
          "state": "Georgia"
        },
        {
          "city": "Atlanta",
          "state": "Georgia"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02357368"
    },
    {
      "nct_id": "NCT01167829",
      "title": "ORAL T-8 Oral Testosterone for Male Hormonal Contraception",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Healthy"
      ],
      "interventions": [
        {
          "name": "Oral Testosterone",
          "type": "DRUG"
        },
        {
          "name": "Acyline",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "University of Washington",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "55 Years",
        "sex": "MALE",
        "summary": "18 Years to 55 Years · Male only"
      },
      "enrollment_count": 14,
      "start_date": "2010-07",
      "completion_date": "2012-06",
      "has_results": true,
      "last_update_posted_date": "2013-09-06",
      "last_synced_at": "2026-09-06T16:34:38.553Z",
      "location_count": 1,
      "location_summary": "Seattle, Washington",
      "locations": [
        {
          "city": "Seattle",
          "state": "Washington"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01167829"
    },
    {
      "nct_id": "NCT02735551",
      "title": "LARC Forward Contraceptive Counseling at MHCC",
      "overall_status": "TERMINATED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE4"
      ],
      "conditions": [
        "Contraception"
      ],
      "interventions": [
        {
          "name": "Long Acting Reversible Contraception (LARC)",
          "type": "DRUG"
        },
        {
          "name": "Referral for Long Acting Reversible Contraception (LARC)",
          "type": "OTHER"
        },
        {
          "name": "Prescription for Short-Acting Hormonal Contraception",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "DRUG",
        "OTHER"
      ],
      "sponsor": "Oregon Health and Science University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "17 Years",
        "maximum_age": "30 Years",
        "sex": "FEMALE",
        "summary": "17 Years to 30 Years · Female only"
      },
      "enrollment_count": 3,
      "start_date": "2016-04",
      "completion_date": "2017-03-31",
      "has_results": true,
      "last_update_posted_date": "2019-11-12",
      "last_synced_at": "2026-09-06T16:34:38.553Z",
      "location_count": 1,
      "location_summary": "Gresham, Oregon",
      "locations": [
        {
          "city": "Gresham",
          "state": "Oregon"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02735551"
    },
    {
      "nct_id": "NCT00065871",
      "title": "The Direct Access Study: Access to Hormonal Birth Control Through Community Pharmacies",
      "overall_status": "UNKNOWN",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Contraception"
      ],
      "interventions": [
        {
          "name": "Contraceptive Screening by Pharmacist",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Contraceptive Prescribing by Pharmacist",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)",
      "sponsor_class": "NIH",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "45 Years",
        "sex": "FEMALE",
        "summary": "18 Years to 45 Years · Female only"
      },
      "enrollment_count": 250,
      "start_date": "2003-06",
      "completion_date": "2006-02",
      "has_results": false,
      "last_update_posted_date": "2007-04-06",
      "last_synced_at": "2026-09-06T16:34:38.553Z",
      "location_count": 5,
      "location_summary": "Kent, Washington • Kirkland, Washington • Puyallup-South Hill, Washington + 2 more",
      "locations": [
        {
          "city": "Kent",
          "state": "Washington"
        },
        {
          "city": "Kirkland",
          "state": "Washington"
        },
        {
          "city": "Puyallup-South Hill",
          "state": "Washington"
        },
        {
          "city": "Seattle",
          "state": "Washington"
        },
        {
          "city": "Seattle-Broadway",
          "state": "Washington"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00065871"
    },
    {
      "nct_id": "NCT05610527",
      "title": "Hormonal Influences on Inflammatory Bowel Diseases",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Inflammatory Bowel Diseases",
        "Contraception",
        "Menstrual Problem"
      ],
      "interventions": [
        {
          "name": "Proposed study design and randomization scenarios",
          "type": "OTHER"
        },
        {
          "name": "Repeated measures of validated Inflammatory Bowel Disease Patient Reported Outcome Instruments",
          "type": "OTHER"
        },
        {
          "name": "Inflammatory marker collection and assessment for correlation with PRO responses and menstrual timing",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER"
      ],
      "sponsor": "University of Utah",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "45 Years",
        "sex": "FEMALE",
        "summary": "18 Years to 45 Years · Female only"
      },
      "enrollment_count": 50,
      "start_date": "2025-07-01",
      "completion_date": "2025-12-09",
      "has_results": false,
      "last_update_posted_date": "2026-04-17",
      "last_synced_at": "2026-09-06T16:34:38.553Z",
      "location_count": 1,
      "location_summary": "Salt Lake City, Utah",
      "locations": [
        {
          "city": "Salt Lake City",
          "state": "Utah"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05610527"
    },
    {
      "nct_id": "NCT04423068",
      "title": "Inpatient Adolescent Contraception",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "EARLY_PHASE1"
      ],
      "conditions": [
        "Pregnancy Related",
        "Contraception",
        "Contraceptive Usage",
        "Contraception Behavior",
        "Pregnancy"
      ],
      "interventions": [
        {
          "name": "SexHealth II",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Contraceptive",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL",
        "DRUG"
      ],
      "sponsor": "Children's Mercy Hospital Kansas City",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "14 Years",
        "maximum_age": "21 Years",
        "sex": "FEMALE",
        "summary": "14 Years to 21 Years · Female only"
      },
      "enrollment_count": 25,
      "start_date": "2020-12-10",
      "completion_date": "2023-04-04",
      "has_results": false,
      "last_update_posted_date": "2023-04-05",
      "last_synced_at": "2026-09-06T16:34:38.553Z",
      "location_count": 1,
      "location_summary": "Kansas City, Missouri",
      "locations": [
        {
          "city": "Kansas City",
          "state": "Missouri"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04423068"
    },
    {
      "nct_id": "NCT01216358",
      "title": "Boston Migraine and Contraception Study",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Headache"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Planned Parenthood League of Massachusetts",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "65 Years",
        "sex": "FEMALE",
        "summary": "18 Years to 65 Years · Female only"
      },
      "enrollment_count": 171,
      "start_date": "2010-10",
      "completion_date": "2011-12",
      "has_results": false,
      "last_update_posted_date": "2012-05-10",
      "last_synced_at": "2026-09-06T16:34:38.553Z",
      "location_count": 1,
      "location_summary": "Boston, Massachusetts",
      "locations": [
        {
          "city": "Boston",
          "state": "Massachusetts"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01216358"
    }
  ]
}